BFRA
Price:
$2.67
Market Cap:
$8.86M
Biofrontera AG, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin. Its principal product is Ameluz, a prescription drug for the treatment of lesion-directed and field-directed actinic keratosis. The company also offers BF-RhodoLED lamp, a photodynamic therapy for lesion-directed and field-directed treatment of actinic keratosis; and Belixos, an over-the-counter line of skin care cosmetic products. In addition, it is developing Ameluz for the treatment of field cancerization and nodular basal cell car...[Read more]
Industry
Biotechnology
IPO Date
2018-02-14
Stock Exchange
NASDAQ
Ticker
BFRA
According to Biofrontera AG’s latest financial reports and current stock price. The company's current Enterprise Value is 6.62M. This represents a change of 16.51% compared to the average of 5.68M of the last 4 quarters.
The mean historical Enterprise Value of Biofrontera AG over the last ten years is 41.41M. The current 6.62M Enterprise Value has changed 1.50% with respect to the historical average. Over the past ten years (40 quarters), BFRA's Enterprise Value was at its highest in in the March 2020 quarter at 60.24M. The Enterprise Value was at its lowest in in the September 2022 quarter at -3655889.00.
Average
41.41M
Median
25.71M
Minimum
3.52M
Maximum
104.08M
Discovering the peaks and valleys of Biofrontera AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 141.63%
Maximum Annual Enterprise Value = 104.08M
Minimum Annual Increase = -96.62%
Minimum Annual Enterprise Value = 3.52M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 5.03M | -39.69% |
| 2023 | 8.34M | 136.70% |
| 2022 | 3.52M | -96.62% |
| 2021 | 104.08M | 141.63% |
| 2020 | 43.08M | -48.98% |
The current Enterprise Value of Biofrontera AG (BFRA) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.63M
5-year avg
32.81M
10-year avg
41.41M
Biofrontera AG’s Enterprise Value is less than IGM Biosciences, Inc. (46.85M), less than Landos Biopharma, Inc. (34.13M), less than Jade Biosciences, Inc. (490.92M), less than Quince Therapeutics, Inc. (194.32M), less than Berkeley Lights, Inc. (42.64M), less than Surface Oncology, Inc. (70.21M), less than Heat Biologics, Inc. (20.56T), less than Miromatrix Medical Inc. (91.30M), greater than Achilles Therapeutics plc (-21604000.00), greater than Reneo Pharmaceuticals, Inc. (-21710584.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 46.85M | $77.50M | |
| 34.13M | $71.68M | |
| 490.92M | $540.28M | |
| 194.32M | $193.77M | |
| 42.64M | $86.61M | |
| 70.21M | $65.08M | |
| 20.56T | $61.07M | |
| 91.30M | $92.95M | |
| -21604000.00 | $60.83M | |
| -21710584.00 | $60.84M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biofrontera AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biofrontera AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Biofrontera AG's Enterprise Value?
What is the highest Enterprise Value for Biofrontera AG (BFRA)?
What is the 3-year average Enterprise Value for Biofrontera AG (BFRA)?
What is the 5-year average Enterprise Value for Biofrontera AG (BFRA)?
How does the current Enterprise Value for Biofrontera AG (BFRA) compare to its historical average?